| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 04/15/2010 | WO2010042867A2 Activators of human pyruvate kinase |
| 04/15/2010 | WO2010042596A2 Photo-activated protecting groups |
| 04/15/2010 | WO2010042500A2 Heat shock protein 90 inhibitors, methods of preparing same, and methods for their use |
| 04/15/2010 | WO2010042489A2 Aminoquinoline derived heat shock protein 90 inhibitors, methods of preparing same, and methods for their use |
| 04/15/2010 | WO2010042163A2 Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders |
| 04/15/2010 | WO2010040992A1 Quinoline derivatives having dp and / or crth2 receptor activity |
| 04/15/2010 | WO2010040989A1 Quinolin-2-one compounds |
| 04/15/2010 | WO2010040808A1 Novel quinolinylamide derivatives useful as modulators of dopamine and serotonin receptors |
| 04/15/2010 | WO2009030467A8 Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides |
| 04/15/2010 | US20100093761 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/15/2010 | US20100093743 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors |
| 04/15/2010 | US20100093726 Novel 4-amino-quinoline derivatives useful as anti-malaria drugs |
| 04/15/2010 | US20100093707 Acid amide derivatives, process for their production and pesticides containing them |
| 04/15/2010 | US20100093681 Napadisylate salt of 5-(2--1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the beta 2 adrenergic receptor |
| 04/15/2010 | CA2740148A1 Activators of human pyruvate kinase |
| 04/14/2010 | EP2173718A2 A method for isolation and purification of montelukast |
| 04/14/2010 | EP2173716A1 A process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates |
| 04/14/2010 | EP2173484A1 Use of metal complex compounds as oxidation catalysts |
| 04/14/2010 | EP1391455B1 Process for preparation of a quinolinecarbaldehyde |
| 04/14/2010 | EP1335901B1 Pharmaceutically active sulfanilide derivatives |
| 04/13/2010 | US7696246 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 04/13/2010 | US7696186 7,9-substituted tetracycline compounds |
| 04/13/2010 | US7695634 Ethylthio-,O-isopropylthionocarbamate at an addition of 5.6% 8-quinolinol; wetting agents;particularly effective at low pH for copper sulfide and molybdenum sulfideores; pyrite-free; hydrometallurgy; industrial scale; efficiency; selectivity |
| 04/13/2010 | CA2425440C Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 04/13/2010 | CA2336807C Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/13/2010 | CA2295678C Pyridine derivatives |
| 04/08/2010 | WO2010039977A2 Heteroaryl antagonists of prostaglandin d2 receptors |
| 04/08/2010 | WO2010037533A1 Glycine b antagonists |
| 04/08/2010 | WO2010018458A3 Phenol derivatives as hif-alpha modulators |
| 04/08/2010 | US20100087649 Quinolinone derivatives |
| 04/08/2010 | US20100087480 Substituted phenylmethyl bicyclocarboxyamide compounds |
| 04/08/2010 | US20100087432 Pyrrole derivatives having crth2 receptor antagonist activity |
| 04/08/2010 | US20100087410 Aryl aniline derivatives as beta2 adrenergic receptor agonists |
| 04/08/2010 | US20100086615 Agent for treatment of pulmonary disease |
| 04/07/2010 | EP2170830A1 Compounds and methods for kinase modulation, and indications therefor |
| 04/07/2010 | EP2170826A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses |
| 04/07/2010 | EP1551829B1 Novel compounds with antibacterial activity |
| 04/07/2010 | EP1527050B1 Quinoline derivatives and their use as mycobacterial inhibitors |
| 04/07/2010 | CN101691355A Substituted 4-quinolinone compounds and preparation method thereof |
| 04/07/2010 | CN101691354A Method for chemically synthesizing 2-heteroaryl substituted quinoline derivatives |
| 04/07/2010 | CN101691319A Method for synthesizing fluoro nitrogen heterocyclic compound |
| 04/06/2010 | US7692018 chromatography, distillation |
| 04/06/2010 | US7692017 Such as 2-(Allyloxy)-4-(3-fluorophenyl)-6-methoxyquinoline-3-carbonitrile; for treating cardiac arrhthymias |
| 04/06/2010 | US7692016 by reaction of aniline/substituted anilines using two different catalysts, ferric chloride and zinc chloride in one-pot set up reaction; cost efficiency |
| 04/06/2010 | CA2513738C Casr antagonist |
| 04/06/2010 | CA2455181C Benzimidazo[4,5-f]isoquinolinone derivatives |
| 04/06/2010 | CA2361057C Quinoline derivatives and quinazoline derivatives |
| 04/01/2010 | WO2010036329A2 Process for making quinolone compounds |
| 04/01/2010 | WO2010036048A2 Method for preparing montelukast sodium salts |
| 04/01/2010 | WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient |
| 04/01/2010 | US20100081806 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 04/01/2010 | US20100081805 Preparation of a Quinolinyloxydiphenylcyclopropanedicarboxamide |
| 04/01/2010 | US20100081688 Process for the preparation of montelukast, and intermediates therefor |
| 04/01/2010 | US20100081686 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter |
| 04/01/2010 | US20100080772 Hepatitis C Virus Inhibitors |
| 04/01/2010 | CA2738236A1 Process for making quinolone compounds |
| 03/31/2010 | EP2168950A1 Inhibitor of the differentiation of t cells into th1 cells |
| 03/31/2010 | EP2168576A2 New utilities of tricyclic compounds |
| 03/31/2010 | EP2167470A1 Triazolo [1, 5-a]quinolines as adenosine a3 receptor ligands |
| 03/31/2010 | EP2167469A1 Sulfonyl-quinoline derivatives |
| 03/31/2010 | EP2167468A2 Process for the preparation and pharmaceutical formulations for 4-quinolinones and quinolines and use thereof |
| 03/31/2010 | CN101687796A Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates |
| 03/31/2010 | CN101687792A Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses |
| 03/31/2010 | CN101687782A Ion channel modulators and methods of use |
| 03/30/2010 | US7687525 e.g. N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; anticarcinogenic, antitumor agents; hematologic malignancy and a solid carcinoma; autoimmune disease, skin disorders; |
| 03/30/2010 | US7687503 2-(methylamino)-2-oxoethyl 4-{5-[3-(trifluoromethyl)-phenyl]-2-pyridyl}-1-piperazinecarboxylate, for example; enzyme inhibitors of fatty acid amide hydrolases; treatment of pain, eating disorders, neurological and psychiatric pathologies, among other disorders |
| 03/30/2010 | US7687282 Detection of transmembrane potentials by optical methods |
| 03/25/2010 | WO2010033685A1 Inhibitors of stat3 |
| 03/25/2010 | WO2010032986A2 Novel 5-(4-aminophenyl)-isoquinoline derivative, pharmaceutically acceptable salt thereof, production method for same, and composition containing same as active ingredient for prophylaxis and treatment of medical condition induced by raf kinase hyperactivity |
| 03/25/2010 | WO2010032886A1 Agricultural composition for controlling or preventing plant disease caused by plant pathogenic bacterium |
| 03/25/2010 | WO2010032881A1 Plant disease control agent |
| 03/25/2010 | WO2009111998A3 Specific impurities of montelukast |
| 03/25/2010 | US20100076195 Purification of montelukast |
| 03/25/2010 | US20100076017 Sitamaquine tosylate for the treatment of leishmaniasis |
| 03/25/2010 | US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 03/25/2010 | US20100075138 Ultra-thin hydrophobic and oleophobic layer, method of manufacture and use in watchmaking as an epilame |
| 03/25/2010 | CA2770302A1 Small molecule compounds for stem cell differentiation |
| 03/25/2010 | CA2737360A1 Inhibitors of stat3 |
| 03/24/2010 | EP2165709A2 Lysine based compounds |
| 03/24/2010 | EP2164828A2 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation |
| 03/24/2010 | EP2164825A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them |
| 03/24/2010 | EP1740545B1 Process for making montelukast and intermediates therefor |
| 03/24/2010 | EP1710236B1 Derivatives of pyridine and quinoline |
| 03/24/2010 | EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/24/2010 | CN101679397A Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity |
| 03/24/2010 | CN101679392A Quinolone compound and pharmaceutical composition |
| 03/24/2010 | CN101679359A Quinolines and their therapeutic use |
| 03/24/2010 | CN101679272A Triazolo [1, 5-a] quinolines as adenosine A3 receptor ligands |
| 03/24/2010 | CN101679271A Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases |
| 03/24/2010 | CN101679270A dihydroquinone and dihydronaphthridine inhibitors of jnk |
| 03/24/2010 | CN101679269A Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the beta 2 adrenergic receptor |
| 03/24/2010 | CN101679268A Process for the preparation of sodium salt of l-(((l(r)-(3-(2-(7-chloro-2- quinolinyl)-ethenyl)phenyl)-3-(2-(l-hydroxy-l- methylethyl)phenyl)propyl)sulfanyl)methyl)cyclopropaneacetic acid |
| 03/24/2010 | CN101679191A Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them |
| 03/24/2010 | CN101678014A 杂环激酶调节剂 Heterocycle kinase modulators |
| 03/24/2010 | CN101678007A gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 03/24/2010 | CN100595225C Method for producing molecular engram polyalcohol microsphere and method for separating enrofloxacin thereof |
| 03/23/2010 | US7683172 Urea derivative and process for preparing the same |
| 03/23/2010 | US7683076 N-(4-chlorophenyl)-N-(3-hydroxy-1-methyl-1,2,3,4-tetrahydroquinolin-5-yl)urea; vanilloid receptor (VR1) antagonistic; urinary incontinence, pain, rheumatoid arthritis, nerve injury, ischaemia, neurodegeneration, stroke, and inflammatory disorders, asthma and chronic obstructive pulmonary disorder |
| 03/23/2010 | US7683048 crystal form of 3-methylthiophene-2-carboxylic acid (6S,9R,10S,11S,13S,16R, 17R)-9-chloro-6-fluoro-11-hydroxy-17-methoxycarbonyl-10,13,16-trimethyl-3-oxo-6,7,8,9,10, 11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl ester; asthma, chronic obstructive pulmonary disease; dermatitis |
| 03/18/2010 | WO2010030967A1 4-aryloxyquinolin-2(1h)-ones as mtor kinase and pi3 kinase inhibitors, for use as anti-cancer agents |